Your browser doesn't support javascript.
loading
Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.
Qi, Hui; Kou, Chen; Qi, Yu-Jie; Tang, Bo-Hao; Wu, Yue-E; Jin, Fei; Luo, Xiao-Jing; Shen, Yan-Hua; Guo, Ya-Jie; Qi, Xue; Wang, Ya-Cui; Dong, Qian; Chen, Xing-Kai; Shi, Hai-Yan; Zheng, Yi; Zhao, Wei; Shen, A-Dong.
Afiliação
  • Qi H; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institut
  • Kou C; Department of Neonatology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
  • Qi YJ; Neonatal Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Tang BH; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Wu YE; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Jin F; Neonatal Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Luo XJ; Neonatal Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Shen YH; Neonatal Intensive Care Unit, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Guo YJ; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institut
  • Qi X; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institut
  • Wang YC; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institut
  • Dong Q; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Chen XK; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Shi HY; Department of Pharmacy, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.
  • Zheng Y; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Zhao W; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China; Department of Pharmacy, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China. Electronic address: zhao4wei2@hotmail.com.
  • Shen AD; Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institut
Int J Antimicrob Agents ; 53(3): 347-351, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30472290

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antibacterianos / Moxalactam Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antibacterianos / Moxalactam Idioma: En Ano de publicação: 2019 Tipo de documento: Article